Literature DB >> 30056731

Precision medicine in breast cancer.

Yoichi Naito1, Tetsuya Urasaki2.   

Abstract

Precision medicine is a strategy for disease treatment and prevention that considers individual variability in genes, environment, and lifestyle. Historically, breast cancer has been treated according to biomarkers such as estrogen receptor and HER2 status. Currently, multigene assays are widely used to predict the risk of relapse after surgery. Molecular targeted agents have been investigated extensively, and some of them are clinically available to date. This review focuses on precision medicine, especially, genome medicine, in breast cancer.

Entities:  

Keywords:  Precision medicine; expert panel; genetic alteration; molecular targeted agent

Mesh：

Substances：

Year:  2018        PMID： 30056731     DOI： 10.21037/cco.2018.06.04

Source DB:  PubMed          Journal:  Chin Clin Oncol        ISSN： 2304-3865


  17 in total

1.  Development and biological assessment of MMAE-trastuzumab antibody-drug conjugates (ADCs).

Authors:  Sajad Yaghoubi; Tohid Gharibi; Mohammad Hossein Karimi; Muhammad Sadeqi Nezhad; Alexander Seifalian; Reza Tavakkol; Nader Bagheri; Asiyeh Dezhkam; Meghdad Abdollahpour-Alitappeh
Journal:  Breast Cancer       Date:  2020-09-05       Impact factor: 4.239

2.  Downregulation of microRNA-30c-5p was responsible for cell migration and tumor metastasis via COTL1-mediated microfilament arrangement in breast cancer.

Authors:  Bei Pei; Tongyang Li; Qi Qian; Wenqiang Fan; Xiao He; Yulan Zhu; Lingyun Xu
Journal:  Gland Surg       Date:  2020-06

3.  Breast-conserving therapy is safe both within BRCA1/2 mutation carriers and noncarriers with breast cancer in the Chinese population.

Authors:  Xin Huang; Xiu-Yu Cai; Jia-Qi Liu; Wen-Wen Hao; Yi-Dong Zhou; Xiang Wang; Ying Xu; Chang Chen; Yan Lin; Chang-Jun Wang; Yu Song; Qiang Sun
Journal:  Gland Surg       Date:  2020-06

4.  Quality of life and related risk factors after breast reconstruction in breast cancer patients.

Authors:  Xiaoqing Wang; Kepeng Zhu; Liang Ren; Hanbing Li; Shuai Lin; Xiao Qing; Jinlian Wang
Journal:  Gland Surg       Date:  2020-06

5.  Unique integrated stress response sensors regulate cancer cell susceptibility when Hsp70 activity is compromised.

Authors:  Sara Sannino; Megan E Yates; Mark E Schurdak; Steffi Oesterreich; Adrian V Lee; Peter Wipf; Jeffrey L Brodsky
Journal:  Elife       Date:  2021-06-28       Impact factor: 8.140

Review 6.  Actin-Binding Proteins as Potential Biomarkers for Chronic Inflammation-Induced Cancer Diagnosis and Therapy.

Authors:  Yu-Gui Zhang; Jiang-Tao Niu; Hong-Wei Wu; Xin-Lei Si; Shu-Juan Zhang; Dong-Hui Li; Tian-Tian Bian; Yue-Feng Li; Xing-Ke Yan
Journal:  Anal Cell Pathol (Amst)       Date:  2021-06-05       Impact factor: 2.916

7.  Willingness to participate in genome testing: a survey of public attitudes from Qatar.

Authors:  Hanan F Abdul Rahim; Said I Ismail; Amel Hassan; Tasnim Fadl; Salma M Khaled; Bethany Shockley; Catherine Nasrallah; Yara Qutteina; Engi Elmaghraby; Heba Yasin; Dima Darwish; Khalid A Fakhro; Radja Badji; Wadha Al-Muftah; Nahla Afifi; Asmaa Althani
Journal:  J Hum Genet       Date:  2020-07-28       Impact factor: 3.172

8.  Effect of breast-conserving surgery combined with sentinel lymph node biopsy and axillary preservation on the recurrence, metastasis, complications and cosmetic results of early breast cancer patients.

Authors:  Jing Xiang; Shiqin Huang; Youlin Tuo; Yun Wang
Journal:  Gland Surg       Date:  2020-08

Review 9.  Antibody-Drug Conjugates Used in Breast Cancers.

Authors:  Aram J Abbas; Marah F Ibrahim; Maher S Saifo
Journal:  J Oncol       Date:  2021-06-24       Impact factor: 4.375

10.  Curcumol enhances the anti-tumor effects of metformin via suppressing epithelial-mesenchymal transition in triple-negative breast cancer.

Authors:  Gangyue Wang; Yi Dong; Heng Liu
Journal:  Ann Transl Med       Date:  2020-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.